๐ฐ Eppendorf News
Page 38 - Eppendorf News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eppendorf. Real-time updates on events, politics, business and more.
August 31, 2022
/PRNewswire/ -- The "Global In Vitro Fertilization (IVF) Market (2022-2027) by Instrument, Technology, End-User, Geography, Competitive Analysis and the Impact...
August 30, 2022
Adam Hartage, a military veteran and an entrepreneur, aims to build an alternative medical economy in response to what he calls โtyrannyโ in the United States.
August 29, 2022
The Europe molecular diagnostics market is slated to grow exponentially during the forecast period which is 2017 to 2025 due to intense competition between several market players, reports Transparency Market Research.
August 28, 2022
The protective scent that tumour cells spray themselves with suppresses the immune system
August 26, 2022
The substance will now be further optimized, said the researchers. This could eventually lead to the development of novel anti-cancer medications.ย
August 26, 2022
Molecular motors are complex devices composed of many different parts that consume energy to perform various cellular activities. In short, molecular machines transform energy into useful work. Un ...
August 25, 2022
/PRNewswire/ -- As per the report published by The Brainy Insights, the global fermenters market is expected to grow from USD 1.58 billion in 2021 to USD 3.11...
August 24, 2022
The biomedical refrigerators and freezers market is projected to record a CAGR of 5.9% during the forecast period, up from US$ 3.2 Bn in 2020 to reach a valuation of US$ 6 Bn by 2031Biomedical refrigerators and freezers are medical equipment, used for storing various biological samples such as biological reagents, b...
August 24, 2022
German scientists say a drug already approved for other purposes can negate how tumor cells protect themselves from the immune system.
August 23, 2022
Sicker patients in the EAST-AFNET4 trial showed a pronounced survival advantage from early rhythm control, compared with a rate-control-first approach, while those with fewer comorbidities missed out.